LakePharma Symposium - 2018


LakePharma is pleased to organize its annual Symposium to bring together individuals and organizations in the biotech community to discuss the latest developments in biologics.

The 2018 symposium will cover topics such as the latest advances in antibody development, as well as innovative technologies that are helping to bring about the next generation of protein therapeutics and products including cell therapies. 

The conference is designed to benefit scientists currently working in the biopharmaceutical industry who want to improve their awareness of the latest advancements in protein engineering and antibody discovery, as well as non-scientists who seek a better understanding of the processes, challenges and opportunities in the industry.


Friday, October 5, 2018


South San Francisco Conference Center, 255 South Airport Boulevard, South San Francisco, CA 94080

Organizing Committee:

Co-organized by 

Hua Tu, Ph.D.                    CEO, LakePharma, Inc.

Norman Garceau, Ph.D.    VP, Technology, LakePharma, Inc.

Yuko Terasawa, Ph.D.        SVP, Corporate Development, Nanomolar, Inc.


Steven Banerjee,  Founder and CEO, Mekonos

Damien Bates, M.D., Ph.D., FRACS, MBA, Chief Medical Officer & Head of Research at SanBio

Prasun Mishra, Ph.D.,  Founder and CEO, Agility Pharmaceuticals   

Janette Phi, COO, Xcell Biosciences            

Deepak Srivastata, M.D.,  President, Gladstone Institutes    

Hong Tan, Ph.D., CEO, Probe Life 

Yuko Terasawa, Ph.D., SVP, Corporate Development, Nanomolar    

Hua Tu, Ph.D., CEO, LakePharma

Jordon Wang, Ph.D., VP, Antibody Discovery, LakePharma



Please click here to view full PDF AGENDA including speaker bios.


8:00 Breakfast and Registration


8:55 Welcome Remarks


Morning Session I


9:00 – 9:30 am:   Jordon Wang, Ph.D., VP, Antibody Discovery, LakePharma

“LakePharma Antibody Center update”


9:35 – 10:10 am: Deepak Srivastata, M.D.,  President, Gladstone Institutes

 “Cardiac Development: Basis for Disease and Regeneration”

10:15-10:40 Morning Break

Morning Session II: ADCs and Bispecifics


10:45 – 11:20 am: Damien Bates, M.D., Ph.D., FRACS, MBA, Chief Medical Officer & Head of Research, SanBio

 “Clinical Development of MSCs for Chronic Neurological Deficits – the SanBio Experience”


11:20 – 11:55 am: Prasun Mishra, Ph.D.,  Founder and CEO, Agility Pharmaceuticals

“Cell therapy: New Frontiers and New Challenges”

12:00– 1:15 pm: Lunch and Breakout Mini Sessions


12:40 – 1:10 pm: Breakout Mini Sessions


                        Jaymee Davis, Cell Therapy Business Development Manager, Thermo Fisher

                       “Next Generation Cell & Gene Therapy Products: The Market, The Tools, The Future”


                         Yasmina Abdiche, Ph.D., Chief Scientific Officer, Carterra

                          "Accelerating Biotherapeutic Discovery with High Throughput Array SPR”


                         Paul Jurcys, SVP IP Management, Nanomolar

                         "List and License Technologies: Anticipate the Next Technological Breakthrough"

1:15  Brief Remarks


Afternoon Session I


1:20 – 1:50 pm:  Hua Tu, Ph.D., CEO, LakePharma

 “Update on LakePharma”


1:55 – 2:30 pm:  Hong Tan, Ph.D., CEO, Probe Life

"BLI and Beyond"

2:30 – 3:00 Poster Session and Break

Afternoon Session II


3:05 – 3:40 pm: Steven Banerjee,  Founder and CEO, Mekonos      

 “Point-of-care Gene Therapies using Silicon Chip Architecture”


3:45 – 4:20 pm: Janette Phi, COO, Xcell Biosciences

 “Control Phenotypic and Genotypic Profiles in Conjunction with Rapid Expansion of Immune Cells, Stem Cells and Tumor Organoids by Mimicking the Human Microenvironment” 




4:30 – 5:30  Networking and Happy Hour




Online registration is now closed. Onsite registration will open at 8 am.


Please click here to view full PDF AGENDA including speaker bios.



Limited space is available for onsite registration on Friday, first come, first served.
Please contact for more information.


List of sponsors image